A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.
| Autor principal: | |
|---|---|
| Otros Autores: | |
| Formato: | Tesis |
| Lenguaje: | English |
| Publicado: |
Brac University
2024
|
| Materias: | |
| Acceso en línea: | http://hdl.handle.net/10361/24298 |